Ischemic Stroke Prevention After Intracerebral Hemorrhage

被引:0
作者
Asad, Syed Daniyal [1 ]
Kozberg, Mariel Gailey [2 ]
机构
[1] Hartford Hosp, Hartford, CT USA
[2] Massachusetts Gen Hosp, Boston, MA USA
关键词
Intracerebral hemorrhage; Ischemic stroke; Anticoagulation; Recurrent intracerebral hemorrhage; Antiplatelets; ATRIAL APPENDAGE CLOSURE; CEREBRAL AMYLOID ANGIOPATHY; HIGH-RISK PATIENTS; INTRACRANIAL HEMORRHAGE; ANTIPLATELET THERAPY; ORAL ANTICOAGULANTS; ANTITHROMBOTIC THERAPY; AGGRESSIVE REDUCTION; SECONDARY PREVENTION; OPEN-LABEL;
D O I
10.1007/s11936-023-00996-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewSurvivors of intracerebral hemorrhage (ICH) are not only at risk for recurrent ICH but often also have vascular risk factors which predispose them to ischemic events. Therefore, clinicians must balance ischemic risk with hemorrhagic risk. This review focuses on ischemic stroke prevention in ICH survivors, particularly the use of antithrombotic medications and the management of hyperlipidemia and hypertension.Recent FindingsWhile previous randomized controlled trials (RCTs) of antithrombotic therapy in stroke prevention excluded survivors of ICH, recent RCTs such as SoSTART, APACHE-AF, and RESTART shed more light into safety and risks of using antithrombotic therapy. Additionally, new imaging biomarkers of increased recurrent ICH risk can help inform treatment choices.Recent data suggests that antiplatelet agents are generally safe in ICH survivors, but these should not be used without an indication. However, the use of anticoagulants may lead to higher rates of recurrent ICH (and higher mortality) in patients with both deep and lobar hemorrhages. Therefore, shared decision-making is paramount including individualized risk stratification and exploration of potential alternatives to antithrombotic therapy. Multiple additional RCTs are ongoing to study the safety of anticoagulation in this high-risk group.
引用
收藏
页码:325 / 345
页数:21
相关论文
共 50 条
  • [41] Ethnic Disparities in Ischemic Stroke, Intracerebral Hemorrhage, and Subarachnoid Hemorrhage Incidence in The Netherlands
    Agyemang, Charles
    van Oeffelen, Aloysia A. M.
    Norredam, Marie
    Kappelle, L. Jaap
    Klijn, Catharina J. M.
    Bots, Michiel L.
    Stronks, Karien
    Vaartjes, Ilonca
    STROKE, 2014, 45 (11) : 3236 - 3242
  • [42] Role of Blood Biomarkers in Differentiating Ischemic Stroke and Intracerebral Hemorrhage
    Bhatia, Rohit
    Warrier, Anand R.
    Sreenivas, Vishnubhatla
    Bali, Prerna
    Sisodia, Pranjal
    Gupta, Anchal
    Singh, Nishita
    Srivastava, M. V. Padma
    Prasad, Kameshwar
    NEUROLOGY INDIA, 2020, 68 (04) : 824 - 829
  • [43] Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage
    Seiffge, David J.
    Kagi, Georg
    Michel, Patrik
    Fischer, Urs
    Bejot, Yannick
    Wegener, Susanne
    Zedde, Marialuisa
    Turc, Guillaume
    Cordonnier, Charlotte
    Sandor, Peter S.
    Rodier, Gilles
    Zini, Andrea
    Cappellari, Manuel
    Schadelin, Sabine
    Polymeris, Alexandros A.
    Werring, David
    Thilemann, Sebastian
    Maestrini, Ilaria
    Berge, Eivind
    Traenka, Christopher
    Vehoff, Jochen
    De Marchis, Gian Marco
    Kapauer, Monika
    Peters, Nils
    Sirimarco, Gaia
    Bonati, Leo H.
    Arnold, Marcel
    Lyrer, Philippe A.
    De Maistre, Emmanuel
    Luft, Andreas
    Tsakiris, Dimtrios A.
    Engelter, Stefan T.
    ANNALS OF NEUROLOGY, 2018, 83 (03) : 451 - 459
  • [44] Acute splenic responses in patients with ischemic stroke and intracerebral hemorrhage
    Vahidy, Farhaan S.
    Parsha, Kaushik N.
    Rahbar, Mohammad H.
    Lee, MinJae
    Thanh-Tung Bui
    Nguyen, Claude
    Barreto, Andrew D.
    Bambhroliya, Arvind B.
    Sahota, Preeti
    Yang, Bing
    Aronowski, Jaroslaw
    Savitz, Sean I.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (06) : 1012 - 1021
  • [45] Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage
    Sembill, Jochen A.
    Kuramatsu, Joji B.
    Schwab, Stefan
    Huttner, Hagen B.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2019, 1 (01):
  • [46] Antithrombotic and Statin Prescription After Intracerebral Hemorrhage in the Get With The Guidelines-Stroke Registry
    Murthy, Santosh B.
    Zhang, Cenai
    Shah, Shreyansh
    Schwamm, Lee H.
    Fonarow, Gregg C.
    Smith, Eric E.
    Bhatt, Deepak L.
    Ziai, Wendy C.
    Kamel, Hooman
    Sheth, Kevin N.
    STROKE, 2023, 54 (12) : 2972 - 2980
  • [47] Fibrinogen Decrease after Intravenous Thrombolysis in Ischemic Stroke Patients Is a Risk Factor for Intracerebral Hemorrhage
    Vandelli, Laura
    Marietta, Marco
    Gambini, Mariaelena
    Cavazzuti, Milena
    Trenti, Tommaso
    Cenci, Maria A.
    Casoni, Federica
    Bigliardi, Guido
    Pentore, Roberta
    Nichelli, Paolo
    Zini, Andrea
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (02) : 394 - 400
  • [48] Convulsive status epilepticus after ischemic stroke and intracerebral hemorrhage: frequency, predictors, and impact on outcome in a large administrative dataset
    Bateman, Brian T.
    Claassen, Jan
    Willey, Joshua Z.
    Hirsch, Lawrence J.
    Mayer, Stephan A.
    Sacco, Ralph L.
    Schumacher, H. Christian
    NEUROCRITICAL CARE, 2007, 7 (03) : 187 - 193
  • [49] Does ICA Occlusion Frequently Have Intracerebral Hemorrhage after IV Tissue Plasminogen Activator Therapy for Ischemic Stroke?
    Kimura, Kazumi
    Sakai, Kenichiro
    Iguchi, Yasuyuki
    Shibazaki, Kensaku
    Sakamoto, Yuki
    EUROPEAN NEUROLOGY, 2011, 65 (05) : 245 - 249
  • [50] Convulsive status epilepticus after ischemic stroke and intracerebral hemorrhage: frequency, predictors, and impact on outcome in a large administrative dataset
    Brian T. Bateman
    Jan Claassen
    Joshua Z. Willey
    Lawrence J. Hirsch
    Stephan A. Mayer
    Ralph L. Sacco
    H. Christian Schumacher
    Neurocritical Care, 2007, 7 : 187 - 193